BR112019003410A2 - composições e métodos para modulação da microflora gastrointestinal em um canino - Google Patents

composições e métodos para modulação da microflora gastrointestinal em um canino

Info

Publication number
BR112019003410A2
BR112019003410A2 BR112019003410-2A BR112019003410A BR112019003410A2 BR 112019003410 A2 BR112019003410 A2 BR 112019003410A2 BR 112019003410 A BR112019003410 A BR 112019003410A BR 112019003410 A2 BR112019003410 A2 BR 112019003410A2
Authority
BR
Brazil
Prior art keywords
canine
compositions
methods
gastrointestinal microflora
modulating
Prior art date
Application number
BR112019003410-2A
Other languages
English (en)
Inventor
Li Qinghong
Original Assignee
Nestec S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec S.A. filed Critical Nestec S.A.
Publication of BR112019003410A2 publication Critical patent/BR112019003410A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

a presente invenção refere-se a métodos e composições para a modulação da microflora gastrointestinal de um canino. em uma modalidade, um método para a modulação da microflora gastrointestinal em um canino pode compreender administrar ao canino uma composição alimentícia para animais de estimação que compreende de cerca de 25% a cerca de 60% de proteína, de cerca de 5% a cerca de 30% de carboidratos, gordura e fibra; sendo que, após a administração, a razão de bacteroidetes para firmicutes (b/f) do canino é menor do que 0,8.
BR112019003410-2A 2016-09-02 2017-08-25 composições e métodos para modulação da microflora gastrointestinal em um canino BR112019003410A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662382923P 2016-09-02 2016-09-02
US62/382,923 2016-09-02
PCT/IB2017/055140 WO2018042304A1 (en) 2016-09-02 2017-08-25 Compositions and methods for modulating gastrointestinal microflora in a canine

Publications (1)

Publication Number Publication Date
BR112019003410A2 true BR112019003410A2 (pt) 2019-05-21

Family

ID=59923495

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019003410-2A BR112019003410A2 (pt) 2016-09-02 2017-08-25 composições e métodos para modulação da microflora gastrointestinal em um canino

Country Status (10)

Country Link
US (1) US10405563B2 (pt)
EP (1) EP3506767A1 (pt)
JP (1) JP2019528698A (pt)
CN (1) CN109640688A (pt)
AU (1) AU2017318650B2 (pt)
BR (1) BR112019003410A2 (pt)
CA (1) CA3033565A1 (pt)
MX (1) MX2019001903A (pt)
RU (1) RU2742512C2 (pt)
WO (1) WO2018042304A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019189408A1 (ja) * 2018-03-29 2019-10-03 森永乳業株式会社 プロバイオティクスを用いた肥満の治療、体脂肪減少用組成物、及びウエスト周囲径低減用組成物
ES2894351T3 (es) * 2018-09-13 2022-02-14 Gnubiotics Sciences Sa Marcadores de microbioma y usos de los mismos
JP7389807B2 (ja) 2018-12-27 2023-11-30 ソシエテ・デ・プロデュイ・ネスレ・エス・アー イヌ科動物における変性性僧帽弁疾患を診断及び治療するための組成物及び方法
EP3911170A2 (en) * 2019-01-18 2021-11-24 Mars Incorporated Methods and compositions for treating intestinal dysbiosis
CN114040680A (zh) * 2019-01-23 2022-02-11 马斯公司 治疗肠道疾病的方法和组合物
EP3952864A4 (en) * 2019-03-08 2023-05-10 The Regents of the University of California COMPOSITIONS AND METHODS FOR MODULATION OF LIPID AND STEROID METABOLISM
JP2022544380A (ja) * 2019-08-09 2022-10-18 ヴェダンタ バイオサイエンシーズ インコーポレーテッド 病原菌を抑制するための組成物及び方法
US11675846B2 (en) * 2019-09-10 2023-06-13 Allfin Inc. Nutritional balance providing system based on pet health information
GB201914385D0 (en) * 2019-10-04 2019-11-20 Mars Inc Microbiome Interventions
CA3164450A1 (en) * 2019-12-19 2021-06-24 Hill's Pet Nutrition, Inc. Pet food compositions
CN112401071B (zh) * 2020-11-19 2021-08-27 山东龙昌动物保健品有限公司 一种胆汁酸复合菌剂在用于制备肉羊饲料添加剂中的应用
US20230404951A1 (en) * 2022-06-15 2023-12-21 Hill's Pet Nutrition, Inc. Pet Food Compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410063B1 (en) 2000-06-13 2002-06-25 Hill's Pet Nutrition, Inc. Composition and method
AU2003205301A1 (en) 2002-01-22 2003-09-02 Mars, Incorporated Reduction of renal damage in companion animals
US20030138547A1 (en) * 2002-01-22 2003-07-24 Mars, Incorporated Weight management system for animals
ES2318307T5 (es) * 2003-06-03 2013-03-06 Hill's Pet Nutrition, Inc. Composición alimentaria para gatos con mucha proteína y pocos carbohidratos que comprende fibra no fermentable
JP5264702B2 (ja) * 2006-03-29 2013-08-14 ネステク ソシエテ アノニム プロバイオティクスを含有する栄養補助食品
US9386793B2 (en) 2010-08-20 2016-07-12 New York University Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
DK2654453T3 (da) * 2010-12-23 2016-08-29 Hills Pet Nutrition Inc Kæledyrsfodersammensætninger og fremgangsmåder til vægttab og vægtvedligeholdelse
WO2013032744A2 (en) 2011-08-17 2013-03-07 Nume Health, Llc Composition and use of a formulation to increase the ratio of gastrointestinal microbiota in phylum bacteriodites to microbiota of firmuctes phylum
CN102524591B (zh) * 2012-02-14 2013-06-05 长沙绿叶生物科技有限公司 一种肥胖犬用保健日粮
EP2909335B1 (en) 2012-10-17 2018-05-30 Institut National de la Recherche Agronomique Prognostic of diet impact on obesity-related co-morbidities

Also Published As

Publication number Publication date
RU2019108902A (ru) 2020-10-02
US20180064140A1 (en) 2018-03-08
WO2018042304A1 (en) 2018-03-08
US10405563B2 (en) 2019-09-10
MX2019001903A (es) 2019-07-15
JP2019528698A (ja) 2019-10-17
CA3033565A1 (en) 2018-03-08
RU2742512C2 (ru) 2021-02-08
RU2019108902A3 (pt) 2020-10-14
CN109640688A (zh) 2019-04-16
EP3506767A1 (en) 2019-07-10
AU2017318650A1 (en) 2019-02-14
AU2017318650B2 (en) 2021-12-09

Similar Documents

Publication Publication Date Title
BR112019003410A2 (pt) composições e métodos para modulação da microflora gastrointestinal em um canino
CL2018001549A1 (es) Mezcla de hmos
BR112017005693A2 (pt) método para tratar e/ou prevenir uma doença hepática, e, composição farmacêutica.
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
CL2018001007A1 (es) Composiciones farmacéuticas para terapias combinadas (sol. divisional de n° 201702538).
CR20170129A (es) Uso de un agonista dual del receptor de glp-1/glucagón de acción prolongada para el tratamiento de la enfermedad del hígado graso no alcohólico
BR112017024684A2 (pt) compostos coagonistas de glucagon e glp-1
BR112018072064B8 (pt) Uso de triglicerídeos de cadeia média para preparação de composições nutricionais para proteção cardíaca em animais de estimação
CL2020000632A1 (es) Composición y método para el tratamiento del autismo.
BR112018000236A2 (pt) composições nutricionais e métodos para a promoção do desenvolvimento cognitivo
PH12018500090A1 (en) Nutritional compositions and methods for promoting cognitive development
BR112017024940A2 (pt) composições de óleo essencial e seu método
DOP2016000102A (es) (aza)piridopirazolopirimidinonas e indazolopirimidinonas y su uso
BR112018005905A2 (pt) ?composto, composição farmacêutica, métodos para evitar ou tratar uma doença ou condição, lesões de órgão, hepatotoxicidade e fígado gorduroso, e, uso de um composto?
AR102085A1 (es) Composición nutricional para el entorno gastrointestinal para la provisión de un perfil metabólico y microbioma mejorados
BR112017025664A2 (pt) composições e métodos para aumentar a neurogênese em animais
BR112018000242A2 (pt) composições nutricionais contendo fosfatidiletanolamina, esfingomielina e ácido doco-saexaenóico
BR112017026241A2 (pt) composições farmacêuticas e alimentícias para induzir a saciação e prolongar a saciedade em indivíduos que necessitem das mesmas
BR112016027043A8 (pt) combinação, composição farmacêutica compreendendo glucocorticoide e edo-s101, kit e uso no tratamento de câncer
BR112017000312A2 (pt) sistema de tratamento da saúde bucal para a aplicação de fosfato de cálcio amorfo, uso de um ou mais aminoácidos básicos, composição, e uso de um ou mais aminoácidos em um sistema de tratamento da saúde bucal
EA201890457A1 (ru) Комбинации антитела против ox40 и модулятора tlr4 и их применение
BR112018000786A2 (pt) métodos e composições usando bifidobacterium longum para modular a reatividade emocional e tratar ou evitar perturbações subclínicas do estado de humor
AR112291A1 (es) Composición para su uso en la prevención y/o el tratamiento de la mucositis orogastrointestinal inducida por un tratamiento oncológico
BR112017007066A2 (pt) composições e métodos para melhorar a mobilidade ou a atividade, ou tratar a debilidade
BR112017004325A2 (pt) composição nutricional para uso na promoção da maturação e/ou do reparo do intestino e/ou do fígado

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: SOCIETE DES PRODUITS NESTLE S.A. (CH)

B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.